Clinical Trials Browser

Phase 2 × LY3214996 × Clear all

NCT04386057 2025-02-12

LY3214996 +/- HCQ in Pancreatic Cancer

Phase 2 Completed

52 enrolled 17 charts

Gastrointestinal

Pancreatic Neoplasms

NCT04534283 2024-08-07

A Basket Trial of an ERK1/2 Inhibitor (LY3214996) in Combination With Abemaciclib.

Phase 2 Terminated

16 enrolled 11 charts

Neoplasm Metastasis, Neoplasms